Table 1.
Training Cohort: Patient, Disease, and Treatment Characteristics
| Parameter | N (%) | Parameter | N (%) |
|---|---|---|---|
| Number of Patients | 36 | Sorafenib Transplant recipient Distant Metastasis Lymph Node Metastasis Hepatitis B Hepatitis C Cirrhosis Ascites Encephalopathy |
8 (22.2) 5 (13.9) 2 (5.6) 3 (8.3) 3 (8.3) 28 (77.8) 5 (13.9) 5 (13.9) 2 (5.6) |
| Treatment Modality | |||
| Conventional TACE | 30 (83) | ||
| DEE-TACE | 6 (17) | ||
| Gender | |||
| Male | 31 (86.1) | ||
| Female | 5 (13.9) | BCLC stage | |
| Race | 0 | 1 (2.8) | |
| White | 23 (63.9) | A | 12 (33.3) |
| African American | 8 (22.2) | B | 10 (27.8) |
| Asian/Pacific Islander | 2 (5.6) | C | 13 (36.1) |
| Other | 3 (8.3) | ||
| ECOG Performance Status | Parameter | Mean (SD) | |
| 0 | 24 (66.7) | Albumin | 3.98 (0.5) |
| 1 | 10 (27.8) | Bilirubin | 0.9 (0.5) |
| 2 | 2 (5.5) | INR | 1.1 (0.1) |
| Child Pugh Class | Tumor Size (cm) | 5.2 (3.0) | |
| A | 31 (86.1) | Number of Tumors | 2.6 (1.1) |
| B | 4 (11.1) | Age | 62.0 (8.9) |
| C | 1 (2.8) |
Clinical, disease, and treatment characteristics of the patient cohort used to train the machine learning model. Liver transplantation occurred strictly after TACE in all patients who were transplanted.
Abbreviations: trans-arterial chemoembolization, TACE; drug-eluting embolic agents, DEE; standard deviation, SD; Barcelona Clinic Liver Cancer, BCLC